Frontlight ResearchEarly access
Myelodysplastic syndromes trials in United States
224 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleVenetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 116
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03214562 - Phase 2Taking peopleHaplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- Where
- Bethesda
- Age
- 4 years to 75 years
- People
- 56
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03520647 - Phase 2Taking peopleMYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Where
- ‘Aiea, Albany, Albuquerque, Allentown, Anaconda, Ankeny, Ann Arbor, Appleton, Ashland, Augusta, Aurora, Baltimore, Barrington, Basking Ridge, Baton Rouge, Bellevue, Bemidji, Berkeley, Bethesda, Billings, Birmingham, Bismarck, Bloomington, Boiling Springs, Boise, Boston, Bozeman, Brighton, Brunswick, Buffalo, Burlington, Caldwell, Camden, Canton, Carthage, Chapel Hill, Charleston, Charlotte, Charlottesville, Chelsea, Chicago, City of Saint Peters, Cleveland, Clinton Township, Clive, Coeur d'Alene, Collierville, Columbus, Commack, Coon Rapids, Creve Coeur, Crystal Lake, Cudahy, Danville, Decatur, Deer River, DeKalb, Des Moines, Detroit, Dixon, Downers Grove, Dublin, Duluth, Durham, Easley, Eau Claire, Edina, Edmonds, Effingham, Elgin, Eureka, Evanston, Fairfax, Fairway, Falls Church, Fargo, Farmington, Farmington Hills, Flint, Fremont, Fresno, Fruitland, Gainesville, Galesburg, Geneva, Germantown, Glenview, Grafton, Grayslake, Great Falls, Green Bay, Greenville, Greer, Grenada, Harvey, Hays, Hazel Crest, Hershey, Hibbing, Highland Park, Hines, Honolulu, Houston, Indianapolis, Iowa City, Irvine, Issaquah, Jackson, Jacksonville, Janesville, Kalispell, Kansas City, Kenosha, Kewanee, Knoxville, La Crosse, Lake Forest, Lake Success, Las Vegas, Lawrence, Lebanon, Lee's Summit, Lewistown, Lexington, Libertyville, Little Rock, Livingston, Livonia, Long Beach, Long Branch, Los Angeles, Louisville, Macomb, Madison, Manhasset, Marinette, Marshfield, Mattoon, Maywood, Memphis, Menomonee Falls, Meridian, Miami, Middletown, Milwaukee, Minneapolis, Minocqua, Missoula, Modesto, Montvale, Mukwonago, Nampa, New Albany, Newberg, New Berlin, New Brunswick, New Haven, New York, Novi, Oak Creek, Oakland, Oak Lawn, Oconomowoc, Oconto Falls, O'Fallon, Oklahoma City, Olathe, Omaha, Ontario, Orange, Oregon City, Orland Park, Oshkosh, Ottawa, Overland Park, Oxford, Palos Heights, Paramus, Park Ridge, Pekin, Pella, Pembroke Pines, Peoria, Peru, Philadelphia, Phoenix, Pittsburgh, Pontiac, Portland, Post Falls, Princeton, Providence, Racine, Reno, Rice Lake, Richmond, Ridgewood, Rochester, Roseville, Ruskin, Sacramento, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, Salina, Salt Lake City, Sandpoint, San Francisco, San Jose, San Leandro, San Rafael, Santa Clara, Santa Rosa, Scarborough, Seattle, Seneca, Sheboygan, Sioux Falls, Southhaven, South Portland, South San Francisco, Springfield, Stevens Point, St Louis, Stony Brook, Sturgeon Bay, Sullivan, Summit, Syracuse, Tampa, The Bronx, Toms River, Topeka, Tucson, Two Rivers, Uniondale, Urbana, Vallejo, Virginia, Walnut Creek, Warrenville, Washington, Waukee, Waukesha, Wauwatosa, Wesley Chapel, West Allis, West Bend, West Bloomfield, West Des Moines, West Haven, Weston, West Reading, Westwood, Wilkes-Barre, Wilmington, Winston-Salem, Worcester, Ypsilanti
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05564390 - Phase 1Taking peopleAutologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 86
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06904066 - Phase 1Taking peoplePhase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
- Where
- Fairfax, New York
- Age
- 18 years and over
- People
- 54 worldwide
- Run by
- Amphista Therapeutics Ltd
See details and how to joinNCT07723703 - Phase 1Not yet taking people in United StatesMaintenance Treatment With Imetelstat in Patients With High-Risk Myeloid Neoplasms After Allo-SCT
- Where
- Madison
- Age
- 18 years to 80 years
- People
- 27
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT07909733 - Phase 1Taking people225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
- Where
- Duarte
- Age
- 18 years to 70 years
- People
- 15
- Run by
- City of Hope Medical Center
See details and how to joinNCT06287944 - No phaseTaking peopleA Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
- Where
- Charlotte, Houston, Winston-Salem
- People
- 49
- Run by
- ARCE Therapeutics, Inc.
See details and how to joinNCT06906380 - No phaseTaking peopleMosaic Trial for Stem Cell Transplant Recipients
- Where
- Chicago, Nutley, Washington D.C.
- Age
- 18 years and over
- People
- 356
- Run by
- Northwestern University
See details and how to joinNCT06960993 - No phaseTaking peopleNatural History Study of GATA2 Deficiency and Related Disorders
- Where
- Bethesda
- Age
- 2 years to 100 years
- People
- 600
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT01905826 - No phaseTaking peopleCancer Experience Registry (CER) for Cancer Patients and Caregivers
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 15,000
- Run by
- Cancer Support Community, Research and Training Institute, Philadelphia
See details and how to joinNCT02333604 - Phase 2Taking peopleTrial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
- Where
- Birmingham
- Age
- 18 years to 75 years
- People
- 56
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06265584 - Phase 1Taking peopleStudy of REM-422 in Patients With AML or Higher Risk MDS
- Where
- Boston, Duarte, Houston, New York, Tampa
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Remix Therapeutics
See details and how to joinNCT06297941 - Phase 1Taking peopleProphylactic DLI-X for Leukemia Relapse After HCT
- Where
- Tucson
- Age
- Up to 65 years
- People
- 180
- Run by
- University of Arizona
See details and how to joinNCT07254793 - No phaseTaking peopleTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Where
- Chapel Hill
- Age
- 18 years to 120 years
- People
- 15,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643 - Phase 1/2Taking peopleCLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Where
- Atlanta, Aurora, Birmingham, Boston, Buffalo, Cincinnati, Duarte, Durham, Houston, Jacksonville, Los Angeles, Miami, New York, Phoenix, Rochester, Tampa
- Age
- 18 years and over
- People
- 275
- Run by
- Cullinan Therapeutics Inc.
See details and how to joinNCT05143996 - No phaseTaking peopleHEME Home Transfusion Program
- Where
- Boston
- Age
- 18 years and over
- People
- 700
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06487247 - Phase 2Not yet taking people in United StatesStudy of Allogeneic Stem Cell Transplant in Myelodysplastic Syndrome Following Conditioning With Fludarabine and Total Body Irradiation 800 cGy
- Where
- Los Angeles
- People
- 20
- Run by
- Ronald Paquette
See details and how to joinNCT07896928 - No phaseTaking peopleCollection of Tissue Samples for Cancer Research
- Where
- Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Buffalo, Charleston, Charlottesville, Columbus, Indianapolis, Iowa City, Pittsburgh, Sacramento, Salt Lake City, Seattle, St Louis
- Age
- 2 months and over
- People
- 5,000 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00900198 - Phase 1Taking peopleAlpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Where
- Madison
- Age
- 7 months to 21 years
- People
- 22
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT02508038 - Phase 2Taking peopleCord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Where
- Seattle
- Age
- 6 months to 65 years
- People
- 54
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06013423 - Phase 2Taking peopleCMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Age
- 18 years to 75 years
- People
- 216
- Run by
- City of Hope Medical Center
See details and how to joinNCT06059391 - Phase 1Taking peopleA Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Age
- 18 years to 75 years
- People
- 46
- Run by
- City of Hope Medical Center
See details and how to joinNCT07020533 - Phase 1/2Taking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Chapel Hill, Decatur, Durham, Houston, New York, Portland
- Age
- 16 years and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - Phase 1/2Taking peopleStudy of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Where
- Ann Arbor, Atlanta, Aurora, Canton, Cleveland, Columbus, Duarte, East Brunswick, Gettysburg, Gilbert, Houston, Iowa City, Irvine, Jacksonville, Los Angeles, Maumee, Miami, Milwaukee, New York, Philadelphia, Portland, Rochester, Rolling Meadows, San Francisco, Seattle, St Louis, Tampa, Temple, Winston-Salem
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Disc Medicine, Inc
See details and how to joinNCT05320198